{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:44:37Z","timestamp":1782780277532,"version":"3.54.5"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T00:00:00Z","timestamp":1777075200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"vor","delay-in-days":66,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-49032-x","type":"journal-article","created":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T07:03:40Z","timestamp":1777100620000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Subclinical overhydration predicts lower time in range and greater glycemic variability in type 2 diabetes on hemodialysis"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3707-7450","authenticated-orcid":false,"given":"Pedro","family":"Gil-Mill\u00e1n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ascensi\u00f3n","family":"Lupia\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Caparr\u00f3s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Ribas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaira","family":"Martinez-Vaquera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1ngel","family":"Ortiz-Zu\u00f1iga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Sim\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga Sim\u00f3","family":"Servat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,25]]},"reference":[{"key":"49032_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fendo.2022.869899","volume":"13","author":"J Ling","year":"2022","unstructured":"Ling, J., Ng, J. K. C., Chan, J. C. N. & Chow, E. Use of continuous glucose monitoring in the assessment and management of patients with diabetes and chronic kidney disease. Front. Endocrinol. (Lausanne) 13, 1\u201313 (2022).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"49032_CR2","doi-asserted-by":"publisher","first-page":"2864","DOI":"10.2337\/dc14-1296","volume":"37","author":"KR Tuttle","year":"2014","unstructured":"Tuttle, K. R. et al. Diabetic kidney disease: a report from an ADA consensus conference. Diabetes Care 37, 2864\u20132883 (2014).","journal-title":"Diabetes Care"},{"key":"49032_CR3","doi-asserted-by":"publisher","first-page":"S22","DOI":"10.1053\/j.ajkd.2013.10.049","volume":"63","author":"ME Williams","year":"2014","unstructured":"Williams, M. E. & Garg, R. Glycemic management in ESRD and earlier stages of CKD. Am. J. Kidney Dis. 63, S22\u2013S38 (2014).","journal-title":"Am. J. Kidney Dis."},{"key":"49032_CR4","doi-asserted-by":"publisher","unstructured":"Paz Ramirez, S. B. et al. Hemoglobin A 1c Levels and Mortality in the Diabetic Hemodialysis Population Findings from the Dialysis Outcomes and Practice Patterns Study (DOPPS). https:\/\/doi.org\/10.2337\/dc12-0573 (2012)","DOI":"10.2337\/dc12-0573"},{"key":"49032_CR5","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1016\/S0140-6736(20)32374-6","volume":"396","author":"JCN Chan","year":"2020","unstructured":"Chan, J. C. N. et al. The Lancet Commission on diabetes: using data to transform diabetes care and patient lives. The Lancet 396, 2019\u20132082 (2020).","journal-title":"The Lancet"},{"key":"49032_CR6","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.nefro.2018.04.004","volume":"38","author":"M Gorostidi","year":"2018","unstructured":"Gorostidi, M. et al. Chronic kidney disease in Spain: Prevalence and impact of accumulation of cardiovascular risk factors. Nefrologia 38, 606\u2013615 (2018).","journal-title":"Nefrologia"},{"key":"49032_CR7","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/j.dsx.2021.05.007","volume":"15","author":"F Alalawi","year":"2021","unstructured":"Alalawi, F. & Bashier, A. Management of diabetes mellitus in dialysis patients: Obstacles and challenges. Diabetes Metab. Syndr. Clin. Res. Rev. 15, 1025\u20131036 (2021).","journal-title":"Diabetes Metab. Syndr. Clin. Res. Rev."},{"key":"49032_CR8","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1159\/000151276","volume":"29","author":"ME Williams","year":"2008","unstructured":"Williams, M. E., Lacson, E., Teng, M., Hakim, R. M. & Lazarus, J. M. Extremes of glycemic control (HbA1c) increase hospitalization risk in diabetic hemodialysis patients in the USA. Am. J. Nephrol. 29, 54\u201361 (2008).","journal-title":"Am. J. Nephrol."},{"key":"49032_CR9","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.2337\/dc24-0635","volume":"47","author":"Y Narasaki","year":"2024","unstructured":"Narasaki, Y. et al. Accuracy of continuous glucose monitoring in hemodialysis patients with diabetes. Diabetes Care 47, 1922\u20131929 (2024).","journal-title":"Diabetes Care"},{"key":"49032_CR10","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.0000000693","author":"IH de Boer","year":"2025","unstructured":"de Boer, I. H. et al. Glycemia assessed by continuous glucose monitoring among people treated with maintenance dialysis. J. Am. Soc. Nephrol. https:\/\/doi.org\/10.1681\/ASN.0000000693 (2025).","journal-title":"J. Am. Soc. Nephrol."},{"key":"49032_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12882-022-02737-3","volume":"23","author":"G Choi","year":"2022","unstructured":"Choi, G. et al. Consistency of the estimated target weights and ECW\/TBW using BIA after hemodialysis in patients between standing and lying-down positions. BMC Nephrol. 23, 1\u201312 (2022).","journal-title":"BMC Nephrol."},{"key":"49032_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/nu11112659","author":"T Yajima","year":"2019","unstructured":"Yajima, T., Yajima, K., Takahashi, H. & Yasuda, K. Combined predictive value of extracellular fluid\/intracellular fluid ratio and the geriatric nutritional risk index for mortality in patients undergoing hemodialysis. Nutrients https:\/\/doi.org\/10.3390\/nu11112659 (2019).","journal-title":"Nutrients"},{"key":"49032_CR13","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1080\/0886022X.2021.1922442","volume":"43","author":"R P\u00e9rez-Morales","year":"2021","unstructured":"P\u00e9rez-Morales, R. et al. Extracellular water\/total body water ratio as predictor of mortality in hemodialysis patients. Ren. Fail. 43, 821\u2013829 (2021).","journal-title":"Ren. Fail."},{"key":"49032_CR14","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1038\/ki.2010.383","volume":"79","author":"JE Flythe","year":"2011","unstructured":"Flythe, J. E., Kimmel, S. E. & Brunelli, S. M. Rapid fluid removal during dialysis is associated with cardiovascular morbidity and mortality. Kidney Int. 79, 250\u2013257 (2011).","journal-title":"Kidney Int."},{"key":"49032_CR15","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1007\/s11255-024-03972-3","volume":"56","author":"M Bossola","year":"2024","unstructured":"Bossola, M. et al. Interdialytic weight gain and low dialysate sodium concentration in patients on chronic hemodialysis: a systematic review and meta-analysis. Int. Urol. Nephrol. 56, 2313\u20132323. https:\/\/doi.org\/10.1007\/s11255-024-03972-3 (2024).","journal-title":"Int. Urol. Nephrol."},{"key":"49032_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2369-14-266","volume":"14","author":"M Antlanger","year":"2013","unstructured":"Antlanger, M. et al. Fluid overload in hemodialysis patients: A cross-sectional study to determine its association with cardiac biomarkers and nutritional status. BMC Nephrol. 14, 266 (2013).","journal-title":"BMC Nephrol."},{"key":"49032_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10204634","author":"JA Gimeno-Orna","year":"2021","unstructured":"Gimeno-Orna, J. A. et al. Association of the KDIGO risk classification with the prevalence of heart failure in patients with type 2 diabetes. J. Clin. Med. https:\/\/doi.org\/10.3390\/jcm10204634 (2021).","journal-title":"J. Clin. Med."},{"key":"49032_CR18","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1161\/CIRCULATIONAHA.108.807362","volume":"119","author":"K Kalantar-Zadeh","year":"2009","unstructured":"Kalantar-Zadeh, K. et al. Fluid retention is associated with cardiovascular mortality in patients undergoing long-term hemodialysis. Circulation 119, 671\u2013679 (2009).","journal-title":"Circulation"},{"key":"49032_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-21226-y","author":"M Tabinor","year":"2018","unstructured":"Tabinor, M. et al. Bioimpedance-defined overhydration predicts survival in end stage kidney failure (ESKF): Systematic review and subgroup meta-analysis. Sci. Rep. https:\/\/doi.org\/10.1038\/s41598-018-21226-y (2018).","journal-title":"Sci. Rep."},{"key":"49032_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-023-41131-3","volume":"13","author":"T Yajima","year":"2023","unstructured":"Yajima, T. & Yajima, K. Association of extracellular water\/total body water ratio with protein-energy wasting and mortality in patients on hemodialysis. Sci. Rep. 13, 1\u20137 (2023).","journal-title":"Sci. Rep."},{"key":"49032_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2021.107930","volume":"35","author":"S Low","year":"2021","unstructured":"Low, S. et al. Higher extracellular water to total body water ratio was associated with chronic kidney disease progression in type 2 diabetes. J. Diabetes Complications. 35, 107930 (2021).","journal-title":"J. Diabetes Complications."},{"key":"49032_CR22","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.19780","volume":"13","author":"A Yang","year":"2025","unstructured":"Yang, A. et al. The association between the extracellular water-to-total body water ratio and albuminuria in Chinese type 2 diabetes mellitus patients. PeerJ 13, e19780 (2025).","journal-title":"PeerJ"},{"key":"49032_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1560902","author":"L Chen","year":"2025","unstructured":"Chen, L. et al. The ratio of extracellular water to total body water serves as a potential predictor of diabetic peripheral neuropathy in patients. Front. Endocrinol. https:\/\/doi.org\/10.3389\/fendo.2025.1560902 (2025).","journal-title":"Front. Endocrinol."},{"key":"49032_CR24","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1111\/1753-0407.13104","volume":"13","author":"S Low","year":"2021","unstructured":"Low, S. et al. Higher ratio of extracellular water to total body water was associated with reduced cognitive function in type 2 diabetes. J. Diabetes. 13, 222\u2013231 (2021).","journal-title":"J. Diabetes."},{"key":"49032_CR25","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1177\/1932296819882690","volume":"14","author":"T Yajima","year":"2019","unstructured":"Yajima, T., Takahashi, H. & Yasuda, K. Comparison of interstitial fluid glucose levels obtained by continuous glucose monitoring and flash glucose monitoring in patients with type 2 diabetes mellitus undergoing hemodialysis. J. Diabetes Sci. Technol. 14, 1088\u20131094 (2019).","journal-title":"J. Diabetes Sci. Technol."},{"key":"49032_CR26","doi-asserted-by":"crossref","unstructured":"Yajima, T. & Yajima, K. Ratio of extracellular water to intracellular water and simplified creatinine index as predictors of all-cause mortality for patients receiving hemodialysis. PLoS One 18, 1\u201311 (2023).","DOI":"10.1371\/journal.pone.0282864"},{"key":"49032_CR27","doi-asserted-by":"publisher","first-page":"393","DOI":"10.23876\/j.krcp.18.0035","volume":"37","author":"H Kim","year":"2018","unstructured":"Kim, H. et al. Changes in bioimpedance analysis components before and after hemodialysis. Kidney Res. Clin. Pract. 37, 393\u2013403 (2018).","journal-title":"Kidney Res. Clin. Pract."},{"key":"49032_CR28","doi-asserted-by":"crossref","unstructured":"KYLE, U. Bioelectrical impedance analysis?part I: review of principles and methods. Clinical Nutrition 23, 1226\u20131243 (2004).","DOI":"10.1016\/j.clnu.2004.06.004"},{"key":"49032_CR29","doi-asserted-by":"crossref","unstructured":"Earthman, C. P. Body Composition Tools for Assessment of Adult Malnutrition at the Bedside. Journal of Parenteral and Enteral Nutrition 39, 787\u2013822 (2015).","DOI":"10.1177\/0148607115595227"},{"key":"49032_CR30","doi-asserted-by":"crossref","unstructured":"Tangvoraphonkchai, K. & Davenport, A. Changes in body composition following haemodialysis as assessed bybioimpedance spectroscopy. Eur. J. Clin. Nutr. 71, 169\u2013172 (2017).","DOI":"10.1038\/ejcn.2016.187"},{"key":"49032_CR31","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.2337\/dc21-0269","volume":"44","author":"A Hayashi","year":"2021","unstructured":"Hayashi, A. et al. Hemodialysis-related glycemic disarray proven by continuous glucose monitoring, Glycemic Markers and Hypoglycemia. Diabetes Care 44, 1647\u20131656 (2021).","journal-title":"Diabetes Care"},{"key":"49032_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s13098-021-00722-8","volume":"13","author":"M Rocha","year":"2021","unstructured":"Rocha, M., Hissa, N., Nogueira Gomes Hissa, P., Guimar\u00e3es, S. B. & Hissa, M. N. Use of continuous glucose monitoring system in patients with type 2 mellitus diabetic during hemodialysis treatment. Diabetol. Metab. Syndr. 13, 104 (2021).","journal-title":"Diabetol. Metab. Syndr."},{"key":"49032_CR33","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1177\/1932296820975057","volume":"15","author":"I Genua","year":"2020","unstructured":"Genua, I. et al. Accuracy of flash glucose monitoring in patients with diabetes mellitus on hemodialysis and its relationship with hydration status. J. Diabetes Sci. Technol. 15, 1308\u20131312 (2020).","journal-title":"J. Diabetes Sci. Technol."},{"key":"49032_CR34","doi-asserted-by":"publisher","first-page":"131","DOI":"10.5414\/CNP86S127","volume":"86","author":"MO Hassan","year":"2016","unstructured":"Hassan, M. O. et al. Correlation between volume overload, chronic inflammation, and left ventricular dysfunction in chronic kidney disease patients. Clin. Nephrol. 86, 131\u2013135 (2016).","journal-title":"Clin. Nephrol."},{"key":"49032_CR35","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1159\/000485153","volume":"45","author":"MJE Dekker","year":"2018","unstructured":"Dekker, M. J. E., Van Der Sande, F. M., Van Den Berghe, F., Leunissen, K. M. L. & Kooman, J. P. Fluid overload and inflammation axis. Blood Purif. 45, 159\u2013165. https:\/\/doi.org\/10.1159\/000485153 (2018).","journal-title":"Blood Purif."},{"key":"49032_CR36","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.freeradbiomed.2010.12.006","volume":"50","author":"JL Rains","year":"2011","unstructured":"Rains, J. L. & Jain, S. K. Oxidative stress, insulin signaling, and diabetes. Free Radical Biol Med. 50, 567\u2013575. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2010.12.006 (2011).","journal-title":"Free Radical Biol Med."},{"key":"49032_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/s0074-7696(05)25005-2","author":"F Schliess","year":"2003","unstructured":"Schliess, F. & H~iussinger, D. Cell volume and insulin signaling. Int. Rev. Cytol. https:\/\/doi.org\/10.1016\/s0074-7696(05)25005-2 (2003).","journal-title":"Int. Rev. Cytol."},{"key":"49032_CR38","doi-asserted-by":"publisher","unstructured":"Frankel, A. H. et al. Diabetes UK Position Statements Management of adults with diabetes on the haemodialysis unit\u202f: summary of guidance from the Joint British Diabetes Societies and the Renal Association. 1018\u20131026 (2018) https:\/\/doi.org\/10.1111\/dme.13676.","DOI":"10.1111\/dme.13676"},{"key":"49032_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/6923543","volume":"2019","author":"A Singhsakul","year":"2019","unstructured":"Singhsakul, A., Supasyndh, O. & Satirapoj, B. Effectiveness of dose adjustment of insulin in type 2 diabetes among hemodialysis patients with end-stage renal disease: a randomized crossover study. J. Diabetes Res. 2019, 1\u20135 (2019).","journal-title":"J. Diabetes Res."},{"key":"49032_CR40","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1159\/000362863","volume":"38","author":"M Gai","year":"2014","unstructured":"Gai, M. et al. Glycemic pattern in diabetic patients on hemodialysis: continuous Glucose Monitoring (CGM) analysis. Blood Purif. 38, 68\u201373 (2014).","journal-title":"Blood Purif."},{"key":"49032_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s41100-022-00429-0","volume":"8","author":"A Hayashi","year":"2022","unstructured":"Hayashi, A. et al. Evaluation of the relationship between hemodialysis-related glycemic variability and hormonal profiles in patients with type 2 diabetes on hemodialysis: a pilot study. Ren. Replace. Ther. 8, 1\u20138 (2022).","journal-title":"Ren. Replace. Ther."},{"key":"49032_CR42","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/hdi.13073","volume":"27","author":"T Bomholt","year":"2023","unstructured":"Bomholt, T. et al. Glucose variability in maintenance hemodialysis patients with type 2 diabetes: comparison of dialysis and nondialysis days. Hemodial. Int. 27, 126\u2013133 (2023).","journal-title":"Hemodial. Int."},{"key":"49032_CR43","first-page":"124","volume":"49","author":"A Schork","year":"2024","unstructured":"Schork, A. et al. SGLT2 inhibitors decrease overhydration and proteasuria in patients with chronic kidney disease: a longitudinal observational study. Kidney Blood Press. Res. 49, 124\u2013134 (2024).","journal-title":"Kidney Blood Press. Res."},{"key":"49032_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-019-0852-y","author":"A Schork","year":"2019","unstructured":"Schork, A. et al. Effect of SGLT2 inhibitors on body composition, fluid status and renin-angiotensin-aldosterone system in type 2 diabetes: a prospective study using bioimpedance spectroscopy. Cardiovasc. Diabetol. https:\/\/doi.org\/10.1186\/s12933-019-0852-y (2019).","journal-title":"Cardiovasc. Diabetol."},{"key":"49032_CR45","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1056\/NEJMoa1515920","volume":"375","author":"C Wanner","year":"2016","unstructured":"Wanner, C. et al. Empagliflozin and progression of kidney disease in type 2 diabetes. N. Engl. J. Med. 375, 323\u2013334 (2016).","journal-title":"N. Engl. J. Med."},{"key":"49032_CR46","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1056\/NEJMoa1811744","volume":"380","author":"V Perkovic","year":"2019","unstructured":"Perkovic, V. et al. Canagliflozin and renal outcomes in type 2 diabetes and nephropathy. N. Engl. J. Med. 380, 2295\u20132306 (2019).","journal-title":"N. Engl. J. Med."},{"key":"49032_CR47","volume":"102","author":"S Vural","year":"2023","unstructured":"Vural, S., Muhtaro\u01e7lu, A. & G\u00fcng\u00f6r, M. Systemic immune-inflammation index: a new marker in differentiation of different thyroid diseases. Medicine (United States) 102, E34596 (2023).","journal-title":"Medicine (United States)"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-49032-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-49032-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-49032-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T23:59:41Z","timestamp":1782777581000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-49032-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,25]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["49032"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-49032-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,25]]},"assertion":[{"value":"7 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19893"}}